You have 9 free searches left this month | for more free features.

City

Beijing (2)

Condition

T2DM (Type 2 Diabetes Mellitus) (1)

Type 2 Diabetes Mellitus (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

Haisco Pharmaceutical Group Co., Ltd. (2)

Collaborator

Intervention

hsk7653 (2)

metformin (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

hsk7653

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Type 2 Diabetes Trial in Beijing (HSK7653, Metformin)

Completed

Type 2 Diabetes Mellitus

HSK7653
Metformin

Beijing, Beijing, China

Peking University Third Hospital

Oct 10, 2023

T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

Completed

T2DM (Type 2 Diabetes Mellitus)

HSK7653
Placebo

Beijing, Beijing, China

Peking Union Medical College Hospital

Aug 1, 2023